VentureBeat September 10, 2020
Kyle Wiggers

Intel and Samsung Medison, a division of Samsung developing ultrasonic devices, today detailed AI-powered, FDA-cleared ultrasound solutions — BiometryAssist and LaborAssist — that automate fetal health measurements. The companies claim BiometryAssist and LaborAssist can deliver a better understanding of a patient’s birthing progress by automatically taking metrics like fetal angle of progression during labor.

According to the World Health Organization, about 295,000 women died during pregnancy and following childbirth in 2017. Research from the Perinatal Institute shows that tracking fetal growth can help prevent stillbirths, as it allows physicians to recognize growth restrictions. But there’s little standardization around fetal measurement because doctors often disagree on where to start.

Intel and Samsung Medison say BiometryAssist and LaborAssist perform measurements in as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Technology
Digital Innovation Plus AI Tech Can Future-Proof the Enterprise
The AI frenzy could fall flat as companies hoard chips without enough data centers to host them
New AI drug discovery powerhouse Xaira rises with $1B in funding
EU regulation: AI Act will mean a raft of new requirements for ‘high-risk’ systems
Why nurses are protesting AI

Share This Article